678
Views
17
CrossRef citations to date
0
Altmetric
Original Article

The effects of ROS in prostatic stromal cells under hypoxic environment

, , , , , , & show all
Pages 84-88 | Received 18 Dec 2014, Accepted 09 Feb 2015, Published online: 09 Mar 2015

References

  • Briganti A, Capitanio U, Suardi N, et al. Benign prostatic hyperplasia and its aetiologies. Eur Urol Suppl 2009;8:865–71
  • Vigneron A, Vousden KH. P53, ros and senescence in the control of aging. Aging (Albany, NY) 2010;2:471–4
  • Passos JF, Von Zglinicki T. Oxygen free radicals in cell senescence: are they signal transducers? Free Radic Res 2006;40:1277–83
  • Saito M, Tsounapi P, Oikawa R, et al. Prostatic ischemia induces ventral prostatic hyperplasia in the SHR: possible mechanism of development of BPH. Sci Rep 2014;22:3822–9
  • Chou PS, Chang WC, Chou WP, et al. Increased risk of benign prostate hyperplasia in sleep apnea patients: a nationwide population-based study. PLoS One 2014;9:e93081
  • Berger AP, Horninger W, Bektic J, et al. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU Int 2006;98:587–90
  • Vela Navarrete R, Garcia Cardoso JV, Barat A, et al. Bph and inflammation: pharmacological effects of permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. Eur Urol 2003;44:549–55
  • Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 1999;232:3–14
  • Semenza GL. Targeting hif-1 for cancer therapy. Nat Rev Cancer 2003;3:721–32
  • Jung SN, Yang WK, Kim J, et al. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via amp-activated protein kinase in du145 human prostate cancer cells. Carcinogenesis 2008;29:713–21
  • Zhou Q, Liu LZ, Fu B, et al. Reactive oxygen species regulate insulin-induced vegf and hif-1alpha expression through the activation of p70s6k1 in human prostate cancer cells. Carcinogenesis 2007;28:28–37
  • Eder IE, Culig Z, Putz T, et al. Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur Urol 2001;40:241–51
  • Hack CE, Hart M, van Schijndel RJ, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60:2835–42
  • Murayama C, Kaji A, Miyauchi K, et al. Effect of vegf (vascular endothelial growth factor) on expression of il-8 (interleukin-8), IL-1beta and their receptors in bovine theca cells. Cell Biol Int 2010;34:531–6
  • Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol 2005;7:S3
  • Vignozzi L, Cellai I, Santi R, et al. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. J Endocrinol 2012;214:31–43
  • Fibbi B, Penna G, Morelli A, et al. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl 2010;33:475–88
  • Zawada WM, Banninger GP, Thornton J, et al. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (mpp+) treated dopaminergic neurons occurs as an nadph oxidase-dependent two-wave cascade. J Neuroinflammation 2011;8:129
  • Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449–65
  • Carrera S, de Verdier PJ, Khan Z, et al. Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis. J Biol Chem 2010;285:13658–65
  • Yuan Y, Zha H, Rangarajan P, et al. Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia. BMC Neurosci 2014;15:125
  • Uchiyama M, Tojo K, Yazawa T, et al. Edaravone prevents lung injury induced by hepatic ischemia–reperfusion. BMC Neurosci 2014;22:125
  • Chen JX, Zhao T, Huang DX. Protective effects of edaravone against cobalt chloride-induced apoptosis in pc12 cells. Neurosci Bull 2009;25:67–74
  • Hänze J, Eul BG, Savai R, et al. RNA interference for hif-1α inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Co 2003;312:571–7
  • Fenter TC, Davis EA, Shah MB, et al. Dutasteride vs. finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged≥ 65 years. Am J Manag Care 2008;14:S154–9
  • Kaplan SA, Lee JY, O'Neill EA, et al. Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Aging Male 2013;16:169–72
  • Kaplan SA, O'Neill E, Lowe R, et al. Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS). Aging Male 2013;16:48–51
  • Hall EJ, Giaccia AJ. Radiobiology for the radiologist. Philadelphia: Wolters Kluwer Health; 2006
  • Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part iii: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490–7
  • Day RM, Suzuki YJ. Cell proliferation, reactive oxygen and cellular glutathione. Dose–Response 2005;3:425–42
  • Misra MK, Sarwat M, Bhakuni P, et al. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009;15:A209–19
  • Parinandi NL, Kleinberg MA, Usatyuk PV, et al. Hyperoxia-induced NAD(p)H oxidase activation and regulation by map kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 2003;284:L26–38
  • Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 1999;48:41–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.